Cerebrolysin for acute ischaemic stroke

LE Ziganshina, T Abakumova… - Cochrane Database …, 2023 - cochranelibrary.com
Background Cerebrolysin is a mixture of low‐molecular‐weight peptides and amino acids
derived from porcine brain, which has potential neuroprotective properties. It is widely used …

Evidence from the Cochrane Collaboration for traditional Chinese medicine therapies

E Manheimer, S Wieland, E Kimbrough… - The Journal of …, 2009 - liebertpub.com
Abstract Background: The Cochrane Collaboration, an international not-for-profit
organization that prepares and maintains systematic reviews of randomized trials of health …

[HTML][HTML] Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: pharmacology and mechanisms

X Li, L Li, W Lei, HZ Chua, Z Li, X Huang… - Biomedicine & …, 2021 - Elsevier
Cardiovascular diseases are one of the leading causes of death worldwide and cardiac
fibrosis is a common pathological process for cardiac remodeling in cardiovascular …

Tongxinluo and functional outcomes among patients with acute ischemic stroke: a randomized clinical trial

Y Dong, K Jiang, Z Li, Y Zhou, B Ju, L Min… - JAMA Network …, 2024 - jamanetwork.com
Importance Previous studies revealed limited effectiveness of neuroprotective agents in
treating acute ischemic stroke (AIS). Tongxinluo, developed from traditional Chinese …

Cochrane systematic reviews of Chinese herbal medicines: an overview

J Hu, J Zhang, W Zhao, Y Zhang, L Zhang, H Shang - PLoS One, 2011 - journals.plos.org
Objectives Our study had two objectives: a) to systematically identify all existing systematic
reviews of Chinese herbal medicines (CHM) published in Cochrane Library; b) to assess the …

The protective role of Tongxinluo on blood–brain barrier after ischemia–reperfusion brain injury

Y Liu, GH Tang, YH Sun, XJ Lin, C Wei… - Journal of …, 2013 - Elsevier
ETHNOPHARMACOLOGICAL RELEVANCE: Tongxinluo (TXL), a renowned traditional
Chinese medicine, consists of several different kinds of ingredients and has been widely …

Traditional Chinese medicines treat ischemic stroke and their main bioactive constituents and mechanisms

G Fan, M Liu, J Liu, Y Huang, W Mu - Phytotherapy Research, 2024 - Wiley Online Library
Ischemic stroke (IS) remains one of the leading causes of death and disability in humans.
Unfortunately, none of the treatments effectively provide functional benefits to patients with …

Complex traditional Chinese medicine for poststroke motor dysfunction: a systematic review

Z Junhua, F Menniti-Ippolito, G Xiumei, F Firenzuoli… - Stroke, 2009 - Am Heart Assoc
Background and Purpose—For its current dimensions, stroke represents the world's primary
health challenge. In China stroke is the second most common cause of death. Traditional …

Tong‐xin‐luo capsule for patients with coronary heart disease after percutaneous coronary intervention

C Mao, XH Fu, JQ Yuan, ZY Yang… - Cochrane Database …, 2015 - cochranelibrary.com
Background Percutaneous coronary intervention (PCI) is a standard treatment for coronary
heart disease (CHD). Restenosis, defined as a 50% reduction in luminal diameter at six …

Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy

J Wang, Y Gao, N Zhang, D Zou, L Xu… - American Journal …, 2014 - journals.physiology.org
Diabetic nephropathy (DN) is one of the most important diabetic microangiopathies. The
epithelial-to-mesenchymal transition (EMT) plays an important role in DN. The physiological …